SpringWorks Therapeutics Inc. was acquired by Merck KGaA in July 2025. SWTX no longer trades, so its trials are no longer stock catalysts and are left off the trial calendar. The records below are kept for reference; the programs now belong to Merck KGaA, and their dates may not have been updated since.
Clinical trial readout dates for SpringWorks Therapeutics Inc., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is May 2027.